Bartolo Colon

Cheating is bad, but are the drugs?

53 Comments

One of the issues many of us have with steroids is that they make players something they’re not. Or so we think anyway. Barry Bonds was practically a superhero in the early part of the last decade. Ryan Braun was probably destined to be a major leaguer, but now we assume that he was never meant to be an MVP. And it’s likely the case that more than a handful of pitchers who would have topped out at Double- or Triple-A otherwise turned themselves into major league relievers for a spell by juicing and adding a few miles per hour to their fastballs.

But what about the other side of juicing? What about the players who just want to be what they were? Many players have used the excuse that they turned to performance-enhancing drugs to aid in the recovery from an injury. Some of those people were undoubtedly lying, but others weren’t. Players want to play.

Bartolo Colon was pretty much written off as a major league pitcher after hurting his shoulder in 2009. Following a controversial surgery in which he had stem cells inserted into his right shoulder, he resurfaced with the Yankees in 2011 and was surprisingly solid, going 8-10 with a 4.00 ERA in 164 1/3 innings. It was the first time he had cracked 100 innings since his Cy Young season in 2005.

Colon performed even better for the A’s in 2011, going 10-9 with a 3.43 ERA, but then he was nabbed for testosterone use. The A’s re-signed him anyway, and this year, he’s been flat-out terrific, going 14-3 with a 2.54 ERA that ranks third in the AL.

We now know that Colon was a Biogenesis client alongside Braun, Alex Rodriguez and others. Many suspect he’s still cheating to this day. Even if he isn’t, he could still be deriving some benefit from the meds he got to help strengthen his shoulder.

And, oddly enough, I just don’t seem to care much about it. In reality, Colon’s crime is the same as Braun’s, and I pretty much despise Braun at the moment.

Colon, though, isn’t something he isn’t supposed to be. Instead, he’s a guy who simply bought himself a few more years. According to Baseball Info Solutions data, Colon is currently defying American League hitters with a fastball that averages all of 90.1 mph. That’s down from 92.7 mph in his Cy Young campaign eight years ago. The data doesn’t go back to when he first came up, but he probably averaged 94-95 mph in the late 90s, often going higher.

Steroids didn’t give Colon the excellent fastball accuracy he’s always enjoyed. They also haven’t helped him master a slider or a curve, which he never really did in the first place. He’s throwing two-seamers and four-seamers 85 percent of the time this year.

Now, maybe Colon’s cocktails will come back to bite him in the long run. We don’t know. Steroid use has always been reported to have dangerous side effects. Since we’ve demonized and criminalized steroid usage, studying whether these more modern regimens could prove relatively harmless is pretty much impossible.

We all like the idea of a level playing field, and if Colon is artificially extending his career, he’s taking a roster spot from a clean player. But, of course, depending on where you want to draw the line, half of the league is composed of guys who are now or will later artificially extend their careers. That’s just modern medicine doing its part.

It’s not like we’re ever going to win the war on performance enhancers. Chemists are always going to come up with new things. Someday, these new things won’t even be frowned upon. We shouldn’t be trying to outlaw substances that make us feel better and look better. We should just be making sure they’re safe.

Someday, people will look at the steroid era and wonder why so many people were so upset. They’ll have moved on. Perhaps not for the better. Perhaps they’ll simply be complaining about genetically engineered people ruining sports.

In the meantime, yes, by all means, punish the cheaters. But don’t pretend that the performance enhancers themselves are a black and white issue. The drugs keep getting better, and they’re not just for bodybuilders and professional athletes. Maybe they should be for everyone.

Orioles are eying Welington Castillo as their primary catcher target

BALTIMORE, MD - SEPTEMBER 25: Welington Castillo #7 of the Arizona Diamondbacks warms up prior to taking an at bat against the Baltimore Orioles in the second inning at Oriole Park at Camden Yards on September 25, 2016 in Baltimore, Maryland. (Photo by Matt Hazlett/Getty Images)
Getty Images
Leave a comment

A report from the Baltimore Sun’s Dan Connolly suggests that free agent catcher Welington Castillo currently tops the Orioles’ list of potential backstop targets for the 2017 season. With Matt Wieters on the market, the Orioles lack a suitable platoon partner for Caleb Joseph behind the dish, and Connolly adds that the club has been discussing a multi-year deal with Castillo’s representatives since the Winter Meetings.

Castillo batted .264/.322/.423 with the Diamondbacks in 2016, racking up 14 home runs and driving in a career-high 68 RBI in 457 PA. His bat provides much of his upside, and Connolly quoted an anonymous National League scout who believes that the 29-year-old’s defensive profile has fallen short of his potential in recent years.

For better or worse, both the Orioles and Castillo appear far from locking in a deal for 2017. Both the Rays and Braves have expressed interest in the veteran catcher during the past week, while the Orioles are reportedly considering Wieters, Nick Hundley and Chris Iannetta as alternatives behind the plate.

Report: Phillies agree to minor league deal with Daniel Nava

KANSAS CITY, MO - SEPTEMBER 12:  Daniel Nava #12 of the Kansas City Royals bats during the game against the Oakland Athletics at Kauffman Stadium on September 12, 2016 in Kansas City, Missouri.  (Photo by Jamie Squire/Getty Images)
Getty Images
2 Comments

The Phillies reportedly signed veteran outfielder Daniel Nava to a minor league contract, according to Matt Gelb of the Philadelphia Inquirer.

Nava began the season on a one-year contract with the Angels, during which he slashed .235/.309/.303 through 136 PA in the first half of 2016. He was flipped to the Royals in late August for a player to be named later and saw the remainder of his year go down the drain on an .091 average through 12 PA in Anaheim. After getting the boot from the Angels’ 40-man roster in November, the 33-year-old outfielder elected free agency.

Nava is expected to compete for a bench role on the Phillies’ roster in the spring. As it currently stands, the club’s projected 2017 outfield features Howie Kendrick and Odubel Herrera, with precious little depth behind them. Nava’s bat is underwhelming, but at the very least he offers the Phillies a warm body in left field and a potential platoon partner for one of their younger options, a la Tyler Goeddel or Roman Quinn.